Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Boston Medical Center, Boston, Massachusetts Mayo Clinic Rochester, Rochester, Minnesota New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin